Search
Ardeparin
go.drugbank.com/drugs/DB00407ApprovedWithdrawnNormiflo was withdrawn from the US market in March 2000.
Carglumic acid
go.drugbank.com/drugs/DB06775ApprovedInvestigationalFood and Drug Administration (FDA) on 18 March 2010.
Elzasonan
go.drugbank.com/drugs/DB18969InvestigationalElzasonan is under investigation in clinical trial NCT00275197 (A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive
Defibrotide
go.drugbank.com/drugs/DB04932ApprovedInvestigationalIn the USA it is was approved in March, 2016 as Defitelio.
Icotrokinra
go.drugbank.com/drugs/DB21724ApprovedInvestigational[L56108,L56118] Icotrokinra was approved by the US FDA in March 2026 for the systemic treatment of moderate-to-severe plaque psoriasis.[L56108]
Erythema Nodosum Leprosum
go.drugbank.com/conditions/DBCOND0036567Drugs: ThalidomideSynonyms: Immune complex reaction co-occurrent and due to multibacillary leprosy, Immune complex reaction co-occurrent and due to multibacillary leprosy (disorder)Salicylic acid
go.drugbank.com/drugs/DB00936ApprovedInvestigationalVet approvedA compound obtained from the bark of the white willow and wintergreen leaves, and also prepared synthetically. It has bacteriostatic, fungicidal, and keratolytic actions. Its salts, the salicylates, are used as analgesics.
Products: CALLICIDA DE MARCH, ACIDO SALICILICO MARCO VITI2,5-Dimethoxy-4-ethylamphetamine
go.drugbank.com/drugs/DB01467ExperimentalIllicitCategories: AmphetaminesMacitentan
go.drugbank.com/drugs/DB08932ApprovedInvestigational[L39105] It was subsequently approved by the FDA in March 2024.[L50622]